N-[(1S)-2-amino-1-(3-chlorophenyl)ethyl]-4-[2-amino-5-(oxan-4-yl)-3-pyridinyl]-2-fluorobenzamide
C25H26ClFN4O2 — CID 134220716
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-2-amino-1-(3-chlorophenyl)ethyl]-4-[2-amino-5-(oxan-4-yl)-3-pyridinyl]-2-fluorobenzamide
N-[(1S)-2-amino-1-(3-chlorophenyl)ethyl]-4-[2-amino-5-(oxan-4-yl)-3-pyridinyl]-2-fluorobenzamide (PubChem CID 134220716) has the molecular formula C25H26ClFN4O2 and a molecular weight of 468.96 g/mol. Its IUPAC name is N-[(1S)-2-amino-1-(3-chlorophenyl)ethyl]-4-[2-amino-5-(oxan-4-yl)-3-pyridinyl]-2-fluorobenzamide.
Molecular Properties
| Compound Name | N-[(1S)-2-amino-1-(3-chlorophenyl)ethyl]-4-[2-amino-5-(oxan-4-yl)-3-pyridinyl]-2-fluorobenzamide |
|---|---|
| PubChem CID | 134220716 |
| Molecular Formula | C25H26ClFN4O2 |
| Molecular Weight | 468.96 g/mol |
| Exact Mass | 468.17 |
| IUPAC Name | N-[(1S)-2-amino-1-(3-chlorophenyl)ethyl]-4-[2-amino-5-(oxan-4-yl)-3-pyridinyl]-2-fluorobenzamide |
| SMILES | NC[C@@H](NC(=O)c1ccc(-c2cc(C3CCOCC3)cnc2N)cc1F)c1cccc(Cl)c1 |
| InChI | InChI=1S/C25H26ClFN4O2/c26-19-3-1-2-17(10-19)23(13-28)31-25(32)20-5-4-16(12-22(20)27)21-11-18(14-30-24(21)29)15-6-8-33-9-7-15/h1-5,10-12,14-15,23H,6-9,13,28H2,(H2,29,30)(H,31,32)/t23-/m1/s1 |
| InChIKey | VPAZEKAFMUCONB-HSZRJFAPSA-N |
| XLogP | 4.45 |
| TPSA | 103.26 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 468.96 |
| LogP ≤ 5 | 4.45 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134220716 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.